Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Lotz

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Therapeutic intensification and autotransplantation of hematopoietic stem cells in metastatic breast cancers]J P Lotz, F Pène, C Bouleuc, et al.
Bone Marrow Transplantation|November 1, 1996
Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancerC Gisselbrecht, J M Extra, J P Lotz, et al.
Contraception, Fertilite, Sexualite (1992)|April 1, 1996
[High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors]J P Lotz, F Pene, C Bouleuc, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCORF Maindrault-Goebel, C Louvet, T André, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility studyT André, J Balosso, C Louvet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2006
High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adultsP Pedrazzoli, J A Ledermann, J-P Lotz, et al.
Bone Marrow Transplantation|June 13, 2000
Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trialS Yanovich, P Mitsky, K Cornetta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR)F Maindrault-Goebel, A de Gramont, C Louvet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR studyT André, C Tournigand, O Rosmorduc, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 1999
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancerE Touboul, L Buffat, Y Belkacémi, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Therapeutic intensification and autotransplantation of hematopoietic stem cells in metastatic breast cancers]J P Lotz, F Pène, C Bouleuc, et al.
Bone Marrow Transplantation|November 1, 1996
Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancerC Gisselbrecht, J M Extra, J P Lotz, et al.
Contraception, Fertilite, Sexualite (1992)|April 1, 1996
[High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors]J P Lotz, F Pene, C Bouleuc, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCORF Maindrault-Goebel, C Louvet, T André, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility studyT André, J Balosso, C Louvet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2006
High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adultsP Pedrazzoli, J A Ledermann, J-P Lotz, et al.
Bone Marrow Transplantation|June 13, 2000
Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trialS Yanovich, P Mitsky, K Cornetta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR)F Maindrault-Goebel, A de Gramont, C Louvet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR studyT André, C Tournigand, O Rosmorduc, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 1999
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancerE Touboul, L Buffat, Y Belkacémi, et al.
Pageof 9